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Helicobacter pylori colonization of the stomach affects about half of the world population
and is associated with the development of gastritis, ulcers, and cancer. Polymorphisms
in the IL1B gene are linked to an increased risk of H. pylori associated cancer, but the
bacterial and host factors that regulate interleukin (IL)-1β production in response to
H. pylori infection remain unknown. Using murine BM-derived DCs, we show that the
bacterial virulence factors cytotoxin-associated genes pathogenicity island and CagL, but
not vacuolating cytotoxin A or CagA, regulate the induction of pro-IL-1β and the produc-
tion of mature IL-1β in response to H. pylori infection. We further show that the host
receptors, Toll-like receptor 2 (TLR2) and nucleotide-binding oligomerization domain 2
(NOD2), but not NOD1, are required for induction of pro-IL-1β and NOD-like receptor
pyrin domain containing 3 (NLRP3) in H. pylori infected DCs. In contrast, NLRP3 and the
adaptor ASC were essential for the activation of caspase-1, processing of pro-IL-1β into
IL-1β, and IL-1β secretion. Finally, we show that mice deficient in caspase-1, IL-1β, and
IL-1 receptor, but not NLRP3, are impaired in the clearance of CagA-positive H. pylori
from the stomach when compared with WT mice. These studies identify bacterial cag
pathogenicity island and the cooperative interaction among host innate receptors TLR2,
NOD2, and NLRP3 as important regulators of IL-1β production in H. pylori infected DCs.
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Introduction
Detection of microbes by the immune system is mediated by the
activation of host soluble factors and germline-encoded pattern-
recognition receptors (PRRs) by microbial moieties or endogenous
molecules generated in the setting of infection [1]. PRRs includ-
ing Toll-like receptors (TLRs), nucleotide-binding oligomerization
domain (NOD) like receptors (NLRs), and retinoic acid-Inducible
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Gene (RIG)-like helicases are activated by conserved and unique
microbial structures [1, 2]. TLRs mediate recognition of several
molecules including LPS and lipopeptides at the cell surface as
well as microbial nucleic acids in endosomes [1]. In contrast, NLRs
and RIG-like helicases induce innate immune responses through
cytosolic sensing of bacterial and viral components [1,2]. TwoNLR
family members, NOD1 and NOD2, are activated by molecules
produced during the synthesis and/or degradation of bacterial
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peptidoglycan [3–6]. Nod2 is activated by muramyl dipeptide,
which is present in all Gram-negative and -positive bacteria [3–6].
In response to infection, TLRs and NOD2 induce transcription of
immune response genes through the transcription factor NF-κB
and MAPKs that ultimately culminate in host defense responses to
eliminate microbial invasion.
A major inflammatory pathway induced in response to micro-
bial infection is the inflammasome, a multiprotein platform that
activates caspase-1 in phagocytes and mast cells [7,8]. Once acti-
vated, caspase-1 cleaves pro-interleukin-1β (IL-1β) and pro-IL-18
into their biologically active secreted forms [7]. To date, sev-
eral inflammasomes have been identified including those trig-
gered by the activation of NLR family members, NLR caspase
domain containing 4 (NLRC4), and NLR pyrin domain containing
3 (NLRP3) [7, 8]. Activation of the NLR caspase domain contain-
ing 4 is induced by the release of bacterial flagellin or PrgJ-like
rod proteins into the host cell cytosol in response to infection with
several bacterial pathogens including Salmonella enterica serovar
Typhimurium, Legionella pneumophila, and Pseudomonas aerugi-
nosa [9]. In mouse macrophages, activation of NLRP3 requires
two signals. The first signal, referred to as priming, is NF-κB-
dependent transcription of pro-IL-1β and Nlrp3, through the stim-
ulation of PRRs by microbial products or certain cytokines such
as tumor necrosis factor-α (TNF-α) or IL-1β [10, 11]. The sec-
ond signal activates NLRP3 and is induced by ATP, certain bacte-
rial toxins, or particulate matter [7–9]. In response to activating
stimuli, NLRP3 recruits the adapter protein ASC (apoptosis-
associated speck-like protein containing a caspase recruitment
and activation domain) to drive the activation of caspase-1
[7].
Helicobacter pylori chronically colonizes the gastric mucosa
of more than 50% of the world population and can persist for
life [12]. Helicobacter pylori infection can induce chronic gas-
tritis, peptic ulcer disease, gastric adenocarcinoma, and gastric
mucosa-associated lymphoid tissue (MALT) lymphoma [12–15].
Helicobacter pylori expresses virulence factors that include vac-
uolating cytotoxin A (VacA) and cytotoxin-associated genes
pathogenicity island (cagPAI) [16, 17]. The cagPAI encodes com-
ponents of a type IV secretion system (T4SS) capable of injecting
into the host cell the CagA protein and other factors that are
associated with more severe inflammatory disease [17]. A major
cytokine induced in response to gastric H. pylori infection is IL-1β
[18]. The importance of IL-1β in H. pylori infection is underscored
by the observation that polymorphisms in the IL1B gene are associ-
ated with an increased predisposition to gastric cancers in infected
individuals [18,19]. Furthermore, transgenic mice overproducing
IL-1β in the stomach develop gastric inflammation and carcinoma
[20]. In dendritic cells (DCs), TLR2 is the major TLR that reg-
ulates cytokine responses to H. pylori infection [21] whereas in
epithelial cell, NOD1 recognizes H. pylori peptidoglycan resulting
in NF-κB activation and subsequent IL-8 production [22]. Heli-
cobacter pylori induces the activation of caspase-1 in DCs [23].
However, little is known about the microbial molecules and host
PRRs that mediate the production of IL-1β in response to H. pylori
infection. In this study, we demonstrate that secretion of IL-1β in
DCs infected with H. pylori is regulated by cagPAI and requires
host TLR2, NOD2, and the NLRP3 inflammasome. Specifically,
H. pylori stimulation via TLR2 and NOD2 in DCs primes the NLRP3
inflammasome by inducing pro-IL-1β and NLRP3, which enables
the activation of caspase-1 via NLRP3 and production of mature
IL-1β. Finally, we provide evidence that IL-1β signaling regulates
the colonization of H. pylori in vivo.
Results
Helicobacter pylori cagPAI and CagL but not VacA or
CagA enhance IL-1β production in DCs
Helicobacter pylori has two major virulence factors, VacA and
cagPAI [16,17]. The cagPAI encodes components of the T4SS [17],
so we determined whether the T4SS is involved in the regulation
of IL-1β. We compared the ability of WT H. pylori and an isogenic
mutant deficient in CagL, a critical component of the T4SS and
cagPAI-associated pili [17], to induce IL-1 β secretion. To deter-
mine whether VacA, cagPAI, and/or CagL regulate IL-1β produc-
tion in H. pylori infected DCs, we infected DCs with WT H. pylori,
and isogenic mutants deficient in VacA, cagPAI, or CagL and found
that IL-1β secretion elicited in DCs infected with either WT or the
H. pylori VacA mutant were comparable (Fig. 1A). However, DCs
infected with cagPAI or CagL mutants had reduced IL-1β secre-
tion when compared with that of cells infected with WT H. pylori
(Fig. 1A). The reduction in IL-1β secretion was not explained by
impaired uptake of the mutant strains by DCs (Fig. 1C). The role
of cagPAI in eliciting IL-1β production was confirmed in a second
H. pylori strain (Fig. 1C). Likewise, impaired IL-1β release was also
observed in another H. pylori strain deficient in CagL (Fig. 1D).
In contrast, a CagA mutant induced comparable IL-1β production
to its isogenic WT strain (Fig. 1E). Consistently, the induction of
IL-1β mRNA by the cagPAI and CagL mutants was impaired com-
pared with that byWT bacteria (Fig. 1F). In contrast, the induction
of Nlrp3 mRNA by the cagPAI and CagL mutants was comparable
with that of the WT bacterium (data not shown). Consistent with
a role of cagPAI and CagL in the induction of IL-1β, the defective
ability of the mutants to induce Il1b mRNA and to elicit IL-1β
secretion was rescued by pretreatment of DCs with LPS (Fig. 1F).
These results indicate that cagPAI and CagL, but not VacA or CagA,
regulate the induction of pro-IL-1β and secondarily the production
of IL-1β in H. pylori infected DCs.
TLR2 and NOD2 regulate pro-IL-1β expression and
IL-1β release upon H. pylori infection in DCs
We next evaluated host factors required for IL-1β secretion in
response to H. pylori infection. Specifically, we tested the abil-
ity of BM-derived DCs (BMDCs) from WT, Tlr2−/−, Nod1−/−,
and Nod2−/− mice to secrete IL-1β in response to infection with
H. pylori 26695. IL-1β secretion was reduced in DCs from Nod2−/−
and Tlr2−/−, but not Nod1−/− mice, when compared with that in
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Figure 1. Helicobacter pylori cagPAI and CagL, but not VacA, enhances IL-1β induction in DCs. (A) DCs were infected with WT P12 H. pylori and
isogenic mutants deficient in VacA, cagPAI, or CagL at a multiplicity of infection (MOI) of 20 overnight. IL-1β production was determined by ELISA.
(B) Uptake of WT P12 H. pylori and isogenic mutants by DCs was measured. (C–E) DCs were infected with indicated WT H. pylori and isogenic
mutants in (C) cagPAI, (D) CagL, and (E) CagA at anMOI of 20 overnight and IL-1β production was determined by ELISA. (F, G) DCs were infected with
WT H. pylori and indicated isogenic mutant strains with or without LPS priming (6 h). (F) The mRNA expression of Il1b was evaluated by real-time
PCR at 6 h after infection and fold increase (arbitrary unit) was obtained by comparison to the level of uninfected DCs. (G) IL-1β production was
determined by ELISA. Data are shown as mean + SD of triplicate samples from one experiment representative of three independent experiments
performed. **p < 0.01, two-tailed Student’s t-test.
DCs from WT mice (Fig. 2A). To determine whether TLR2 and
NOD2 were redundant in the secretion of IL-1β, we generated
mice doubly deficient in TLR2 and Nod2 and infected DCs from
the mutant mice with H. pylori. The release of IL-1β in response to
H. pylori was much lower in DCs from Nod2−/−Tlr2−/− mice than
in DCs from either Tlr2−/− or Nod2−/− mice (Fig. 2B). To deter-
mine whether TLR2 and Nod2 regulate the induction of pro-IL-1β,
DCs from WT, Tlr2−/−, Nod1−/−, Nod2−/−, and Nod2−/−Tlr2−/−
mice were infected with H. pylori and levels of pro-IL-1β induc-
tion were assessed by immunoblotting. We found that pro-IL-1β
was induced upon infection in WT DCs. However, the levels of
induction were reduced to a greater extent in doubly deficient
Nod2−/−Tlr2−/− DCs compared with those in single deficient DCs
(Fig. 2C). To determine whether TLR2 and Nod2 regulate the tran-
scriptional induction of pro-IL-1β, we prepared mRNA from WT
and Nod2−/−Tlr2−/− DCs before and after H. pylori infection and
measured Il1b mRNA by quantitative real-time PCR. Consistent
with the results shown in Figure 2C, the Il1b mRNA levels were
significantly reduced in Nod2−/−, Tlr2−/−, and Nod2−/−Tlr2−/−
DCs (Fig. 2D) after H. pylori infection. These results indicate that
NOD2 and TLR2 have a redundant role in H. pylori induced IL-1β
secretion such that pro-IL-1β induction is significantly impaired in
the absence of both receptors in DCs.
Processing of IL-1β upon H. pylori infection depends
on caspase-1
IL-1β is synthesized as an inactive precursor and can be prote-
olytically cleaved by several proteases including caspase-1 into
its biologically active mature form [24]. To determine whether
H. pylori induced IL-1β processing is dependent on caspase-1, we
first evaluated the secretion of IL-1β in H. pylori infected DCs from
WT or Casp1−/− mice. The release of IL-1β, but not TNF-α, was
impaired in DCs from Casp1−/− mice (Fig. 3A and B). As a con-
trol for pro-IL-1β processing, we also stimulated DCs with LPS and
ATP, a stimulus that potently induces cleavage of pro-IL-1β into its
mature (p17) form via NLRP3 and caspase-1 [11]. Although pro-
IL-1β induction was comparable in H. pylori infected DCs fromWT
and Casp1−/− mice, the processing of pro-IL-1β into IL-1β (p17)
was impaired in DCs from Casp1−/− mice (Fig. 3C). In addition,
infection of DCs with another H. pylori strain SPM326 that can
colonize mice showed the same dependency on caspase-1 for pro-
IL-1β and IL-1β secretion (Fig. 3D–F). These results indicate that
processing and secretion of IL-1β in H. pylori infected DCs requires
caspase-1.
TLR2 and NOD2 induce NLRP3 expression and
pro-IL-1β processing upon H. pylori infection
We showed in Fig. 2 that TLR2 and NOD2 regulate the induc-
tion of pro-IL-1β and IL-1β secretion in H. pylori infected DCs.
To determine whether TLR2 and NOD2 also regulate caspase-1
activation, WT and Nod2−/−Tlr2−/− DCs were infected with
H. pylori and caspase-1 activation was assessed by immuno-
blotting. The production of the p20 subunit of caspase-1 was
induced byH. pylori infection inWT DCs, but was greatly impaired
in Nod2−/−Tlr2−/− DCs (Fig. 4A). Similarly, the amount of
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Figure 2. TLR2 and NOD2 induce pro-IL-1β expression and IL-1β release upon H. pylori infection in DCs. DCs from WT, Tlr2−/−, Nod1−/−, Nod2−/−,
and Nod2−/−Tlr2−/− mice were infected with H. pylori at an MOI of 20 either (A, B) overnight or (C, D) for 6 h. (A, B) IL-1β secretion was determined by
ELISA and (C) induction of pro-IL-1β was analyzed by immunoblotting. Immunoblotting for glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as a loading control. (D) mRNA expression of Il1b was evaluated by real-time PCR and fold increase (arbitrary units) was obtained by
comparison to the level of uninfected DCs. (A, B, D) Data are shown as mean + SD of triplicate samples from one experiment representative of
three independent experiments. *p < 0.05, **p < 0.01, two-tailed Student’s t-test.
processed IL-1β (p17) was reduced in Nod2−/−Tlr2−/− DCs when
compared to WT cells (Fig. 4A). Activation of caspase-1 via the
NLRP3 inflammasome is regulated, in part, by a priming step that
involves the induction of Nlrp3 [21]. Notably, infection of DCs by
H. pylori increased the level of Nlrp3mRNA, which was reduced in
Nod2−/−, Tlr2−/−, and Nod2−/−Tlr2−/− DCs (Fig. 4B). To further
assess a role for NOD2/TLR2 in inflammasome priming (signal 1),
we pretreated DCs with LPS, a stimulus that primes the NLRP3
inflammasome, prior to H. pylori infection. Pretreatment of DCs
with LPS enhanced the production of IL-1β in H. pylori infected
cells and rescued the defective ability of DCs to secrete IL-1β in
response toH. pylori infection (Fig. 4C). These results indicate that
NOD2 and TLR2 contribute to caspase-1 activation via priming of
the inflammasome.
Figure 3. Processing of IL-1β upon H. pylori infection depends on caspase-1. DCs from WT and Casp1−/− mice were infected with H. pylori (A–C)
HP 29965 or (D–F) HP SPM326 at the indicated MOI (A, B, D, E) overnight or (C, F) at an MOI of 100 for 6 h. (A, D) IL-1β and (B, E) TNF-α production
was determined by ELISA and (C, F) induction of pro-IL-1β and p17 was analyzed by immunoblotting. (A, B, D, E) Data are shown as mean + SD of
triplicate samples from one experiment representative of three independent experiments. *p < 0.05, **p < 0.01, two-tailed Student’s t-test.
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Figure 4. TLR2 and NOD2 induce Nlrp3 expression and pro-IL-1β pro-
cessing upon H. pylori infection. (A) DCs from WT and Nod2−/−Tlr2−/−
micewere infectedwithH. pylori at anMOI of 100 for 6 h. The production
of the p20 subunit of caspase-1 and processed IL-1β (p17) was analyzed
by immunoblotting. GAPDHwas used as a loading control. (B) DCs from
WT and indicatedWT andmutant DCswere infectedwithH. pylori at an
MOI of 20 for 6 h. mRNA expression of Nlrp3was evaluated by real-time
PCR and fold increase (arbitrary units) was obtained by comparison to
the level of uninfected DCs. (C) DCs from WT and indicated mutant
DCs were infected with H. pylori overnight with or without LPS priming
(6 h). IL-1β production was determined by ELISA. (B, C) Data are shown
as mean + SD of triplicate samples from one experiment representa-
tive of three independent experiments. *p < 0.05, **p < 0.01, two-tailed
Student’s t-test.
Helicobacter pylori infection activates caspase-1 via the
NLRP3 inflammasome in DCs
We next determined which inflammasome was involved in IL-1β
secretion induced by H. pylori infection. DCs from WT and mice
deficient in Nlrp3, Nlrc4, or the common adaptor Ascwere infected
with H. pylori. IL-1β secretion induced by infection was reduced
in DC deficient in Nlrp3 or Asc, but not in cells deficient in Nlrc4
(Fig. 5A). The impairment in IL-1β secretion in Nlrp3−/− or Asc−/−
DCs was specific in that the production of TNF-α in response to
H. pylori infection was unimpaired (Fig. 5B). Consistently, acti-
vation of caspase-1 and production of mature IL-1β (p17) were
abrogated in Nlrp3−/− and Asc−/− DCs, but not in Nlrc4−/− DCs
(Fig. 5C). These results indicate that caspase-1-dependent IL-1β
processing and secretion requires the NLRP3 inflammasome in
H. pylori infected DCs.
IL-1β signaling regulates H. pylori colonization in vivo
We next determined whether IL-1β signaling regulates the extent
of H. pylori colonization in mice. To assess this, WT and mice
deficient in IL-1β, IL-1 receptor caspase-1, and NLRP3 were orally
infected with H. pylori and bacterial loads were determined in
gastric tissue after infection. The SS1 H. pylori strain is widely
used for in vivo studies. However, the mouse-adapted SS1 strain
lacks a functional Cag T4SS [25], which we have found to be
important for IL-1β production (Fig. 1). Therefore, we used in
these experiments SPM326, a CagA-positive H. pylori strain that
induces robust IL-1β production (Fig. 3D), expresses a functional
Cag T4SS, and colonizes mice at low levels [26]. Consistently, low
or undetectable pathogen colonization was found in the stomach
of WT mice 4 weeks after infection (Fig. 6). Notably, the bacte-
rial loads in the stomach were increased in Il1b−/−, Il1r−/−, and
Casp1−/− mice when compared with those in WT mice (Fig. 6A–
C). In contrast, we found comparable levels of pathogen coloniza-
tion in Nlrp3−/− and WT mice (Fig. 6D). These results indicate
that IL-1β signaling can limit colonization of H. pylori, but this is
NLRP3-independent, in vivo.
Discussion
It is known that the mucosal levels of pro-inflammatory cytokines
such as IL-1β, IL-6, and TNF-α are significantly higher in H. pylori
positive than H. pylori negative gastric specimens [27, 28]. Fur-
thermore, the production of pro-inflammatory cytokines is impor-
tant in the pathogenesis of H. pylori infection and development of
H. pylori associated complications such as cancer [13,18,27,28].
Among these pro-inflammatory cytokines, IL-1β can increase the
expression of other cytokines, such as IL-6 and TNF-α, and regulate
the expression of adhesion molecules and influx of inflammatory
cells [29]. However, the mechanism by which IL-1β is produced in
response to H. pylori infection remains poorly understood. In the
present study, we showed that IL-1β secretion in H. pylori infected
DCs is mediated by cooperative interaction between TLR2/NOD2
and NLRP3. TLR2 and NOD2 are both required for the transcrip-
tional induction of pro-IL-1β and the priming of the inflammasome
that is mediated by the upregulation of NLRP3. Based on the anal-
ysis of single and double deficient cells, the results indicate that
although TLR2 is more critical to the induction of pro-IL-1β and
NLRP3, NOD2 also contributes to this process, which is consistent
with the ability of these PRRs to induce gene expression via NF-κB
and MAPK activation [1, 30]. In contrast, NLRP3 was required
for caspase-1 activation, processing of pro-IL-1β, and the release
of mature IL-1β. These results are in agreement with the current
view of NLRP3 activation that relies on two signals for the assem-
bly of the inflammasome. While TLR2 and NOD2 provide signal
1 through the induction of NLRP3, the identity of signal 2, which
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Figure 5. Helicobacter pylori infection activates
caspase-1 via the NLRP3 inflammasome in DCs.
DCs fromWT andNlrp3−/−,Nlrp4−/−,Asc−/−, and
Nlrc4−/− mice were infected with H. pylori either
(A, B) at the indicated MOI overnight or (C) at an
MOI of 100 for 6 h. (A, B) IL-1β and TNF-α pro-
duction was determined by ELISA and (C) acti-
vated caspase-1 (p20) and processed IL-1β (p17)
was analyzed by immunoblotting. (A, B) Data are
shown as mean + SD of triplicate samples from
one experiment representative of three inde-
pendent experiments. *p < 0.05, **p < 0.01, two-
tailed Student’s t-test.
Figure 6. IL-1β signaling regulates H. pylori colonization in vivo. Heli-
cobacter pylori colonization was determined in the stomach of WT,
(A) Il1b−/−, (B) Il1r−/−, (C) Casp1−/−, and (D)Nlrp3−/− mice 4weeks postin-
fection by quantitative culture. Values are expressed as colony-forming
units (CFUs) per gram stomach tissue. Each symbol represents one
animal and bars represent means. Data shown are pooled from two
experiments. N.S., not significant. Statistical significance determined
by one-way analysis of variance (ANOVA) and Newman–Keuls multiple
comparison test.
activates NLRP3 and is presumably provided by a molecule pro-
duced by H. pylori, remains to be determined. Although NLRP3
was required for IL-1β secretion in DCs infected with H. pylori
in vitro, NLRP3 was not essential to clear the pathogen in the
stomach. Because the clearance of H. pylori was impaired in mice
deficient in IL-1β, IL-1R1, or caspase-1, the results suggest that
the regulation of IL-1β in response to H. pylori infection in vivo is
complex and may involve additional inflammasomes, which is not
revealed in studies with DCs in vitro.
Helicobacter pylori possesses two major virulence factors, VacA
and cagPAI. We provide evidence that cagPAI promotes IL-1β
secretion by enhancing the transcriptional induction of IL-1β
whereas VacA was dispensable. The cagPAI is a 40 kb stretch
of DNA that encodes components of a T4SS that forms a pilus
for the injection of virulence factors into host target cells [17].
The mechanism by which cagPAI regulates transcription of IL-1β
is unclear. The observation that H. pylori deficient in CagL, an
essential component of the Cag T4SS apparatus, is impaired in
inducing IL-1β suggests that effector proteins or other bacterial
molecules injected into the host cytosol via the T4SS might be
involved in the regulation of IL-1β. Notably, CagA, a major effec-
tor that is translocated via the Cag T4SS, was not involved in the
regulation of IL-1β. Previous studies showed that peptidoglycan
fragments can be delivered via the Cag T4SS to the cytosol of
epithelial cells eliciting NOD1 activation [22]. Because NOD2 is
involved in the induction of IL-1β, it is possible that peptidogly-
can molecules containing the muramyl dipeptide motif may be
leaked into the cytosol of DCs, leading to NOD2 activation. How-
ever, we found thatNod1−/−Nod2−/− DCs infected with the cagPAI
mutant still elicited reduced IL-1β secretion when compared with
mutant DCs infected with the WT bacterium (results not shown).
These results suggest that the mechanism by which cagPAI regu-
lates transcription of IL-1β is not via translocation of Nod1/Nod2
microbial agonists into the host cytosol. Because CagL also binds
to β1 integrins on the target cell surface, it is also possible that
interactions between CagL and host receptors on DCs regulate
IL-1β production.
Single-nucleotide polymorphisms of the IL1B gene are associ-
ated with an increased risk for the development of gastric cancer
in the setting of H. pylori infection [18]. The mechanism by which
IL-1β gene variants promote cancer is poorly understood and con-
troversial. For example, some authors have reported that these
genetic polymorphisms are associated with increased production
of IL-1β, which has been suggested to induce hypochlorhydria,
progressive gastric atrophy, and increased risk for gastric cancer
[18]. Using amousemodel of IL-1β overexpression in the stomach,
Tu et al. [20] provided evidence that IL-1β induces the recruit-
ment of myeloid-derived suppressor cells to the stomach and the
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activation of these cells may contribute to cancer development
through the production of IL-6 and TNF-α. However, Sugimoto
et al. [31] reported that IL-1β gene polymorphisms are linked to
lower production of IL-1β in the gastric mucosa of individuals
infected with H. pylori and lower pathogen eradication rate. Our
results are consistent with the latter study in which we found that
IL-1β signaling inhibits H. pylori colonization in mice. However,
Hitzler et al. [23] reported that IL-1R-null mice had compara-
ble colonization of the H. pylori SS1 strain. Unlike the H. pylori
CagA-positive SPM326 strain used in our in vivo studies, the
H. pylori SS1 strain lacks a functional Cag T4SS [25]. Thus, dif-
ferential expression of cagPAI encoded factors that regulate IL-1β
production may account, in part, for the difference in results.
Thus, it is possible that increased H. pylori colonization as a result
of deficient host IL-1β production promotes enhanced inflam-




Animal studies were carried out in accordancewith the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was approved by
the University of Michigan Committee on Use and Care of Animals
(Approved Protocol Number: 09716).
Mice
Nod1−/−, Nod2−/−, Casp1−/−, Asc−/−, Nlrp3−/−, and Nlrc4−/− in
C57BL/6J background have been previously described [32–34].
Mice deficient in TLR2 in C57BL/6J background were a gift from
Dr. Shizuo Akira (Osaka University, Japan). C57BL/6J mice were
originally purchased from The Jackson Laboratory and main-
tained in our laboratory. Mice deficient in both NOD2 and TLR2
were generated by crossing Nod2−/− and Tlr2−/− mice and inter-
crossing the F1 generation. Mice were housed in a pathogen-free
facility.
Reagents and bacterial culture
Ultrapure LPS from Escherichia coli O111:B4 was purchased from
InvivoGen. Helicobacter pylori strain 26695, P1 WT, isogenic
mutant P1 cagL (CagL deficient), P12 WT, isogenic mutant P12
vacA (VacA deficient), P12 cagPAI (cagPAI deficient), and P12
cagL have been described [35]. Helicobacter pylori strain G27
WT and isogenic mutant G27 cagPAI were gifts from Dr. Scott
Merrell (Uniformed Services University of the Health Sciences,
Bethesda, MD, USA) and SPM326 from Dr. Lesley Smythies (Uni-
versity of Alabama, Birmingham, AL, USA). Helicobacter pylori
was routinely grown on Campylobacter agar plates or Brucella
broth containing 10% of FBS, 10 μg/mL of vancomycin (Sigma),
5 μg/mL of trimethoprim (Sigma), and 1 μg/mL of nystatin
(Sigma) at 37◦Cundermicroaerobic conditions.Helicobacter pylori
was isolated from gastric homogenates cultured on plates con-
tained 200 μg/mL of bacitracin (Sigma), 6 μg/mL of vancomycin
(Sigma), 16 μg/mL of cefsulodin (Sigma), and 20 μg/mL of
trimethoprim (Sigma) to inhibit the growth of normal gastric
flora.
Preparation of BMDCs and infection with H. pylori
BMDCs were prepared as previously described [11]. Briefly, BM
cells were cultured with GM-CSF (20 ng/mL), with fresh GM-CSF
added on days 3 and 5. After 7 days, nonadherent cells were
collected by vigorous aspiration. BMDCs were seeded in 48-well
plates (2 × 105/well) for enzyme-linked immunosorbent assay
(ELISA) or six-well plates (5 × 106/well) for immunoblotting and
quantitative PCR and infected with H. pylori overnight or 6 h,
respectively.
Bacterial invasion assay
The invasion efficiency of H. pylori strains was evaluated using
a gentamicin protection assay. Briefly, BMDCs were infected for
20 min and then incubated for 20 min at 37◦C in medium
containing gentamicin (100 μg/mL) to kill extracellular bacteria.
The infected cells were then washed in PBS, lysed in 0.5%
TritonX-100/PBS, and the number of intracellular bacteria was
determined by plating.
Quantitative real-time PCR
RNA was extracted using the RNeasy Mini kit (Qiagen) and cDNA
was prepared from 0.1 μg of RNA using High Capacity RNA-to-
cDNA kit (Applied Biosystems) according to the manufacturer’s
instruction. Quantitative real-time PCR was performed by the
StepOne Real-Time PCR System using SYBR green buffer accord-
ing the manufacturer’s instruction (Applied Biosystems). β-Actin
was used for normalization. The following primer sequences
were used; IL-1β forward: 5′-GATCCACACTCTCCAGCTGCA-3′;
IL-1 β reverse: 5′-CAACCAACAAGTGATATTCTCCATG-3′;
Nlrp3 forward: 5′-ATGGTATGCCAGGAGGACAG-3′; Nlrp3
reverse: 5′-ATGCTCCTTGACCAGTTGGA-3′; Actb forward:
5′-CAATAGTGATGACCTGGCCGT-3′; Actb reverse: 5′-
CAATAGTGATGACCTGGCCGT-3′.
Measurement of cytokines
Mouse cytokines were measured in culture supernatants using the
ELISA kit from R&D systems.
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Immunoblotting
Cells were lysed together with the cell supernatant by the addi-
tion of 1% Nonidet P-40, complete protease inhibitor cocktail
(Roche), and 2 mM dithiothreitol. After centrifugation at 20 000
× g for 15 min, the supernatant was mixed with 5× SDS buffer
and boiled for 10 min, and samples were separated by SDS-
PAGE and transferred to polyvinyldifluoride membranes. Mem-
branes were incubated with rabbit antibody to mouse caspase-1 (a
gift from P. Vandenabeele, University of Ghent, Ghent, Belgium),
goat antibody to mouse IL-1β (R&D systems), and mouse anti-
body to mouse GAPDH (Millipore). Proteins were detected by ECL
kit.
Mouse infection
Mice were inoculated three times by oral gavage with 500 μL
of H. pylori strain SPM326 (2–8 × 109/mL) with 1 day sepa-
rating each inoculation. After 4 weeks, mice were euthanized
by CO2 and stomachs were removed and washed with sterile
water. Washed stomachs were homogenized, plated onto agar
plates, and incubated under microaerobic conditions at 37◦C for
5–7 days.
Statistical analysis
Statistical significance between groups was determined by the
two-tailed Student’s t-test or one-way analysis of variance
(ANOVA) followed by post hoc analysis (Newman–Keuls multiple
comparison test) (Graphpad Prism 5). Differences were consid-
ered significant at p < 0.05.
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